| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Donepezil | FAERS: 3 | US FAERS | |
| 2 | Imatinib Mesylate | FAERS: 3 | US FAERS | |
| 3 | Pregabalin | FAERS: 3 | US FAERS | |
| 4 | Teriparatide | FAERS: 3 | US FAERS | |
| 5 | ropinirole | FAERS: 3 | US FAERS | |
| 6 | Pramipexole | FAERS: 2 | US FAERS | |
| 7 | trametinib | FAERS: 2 | US FAERS | |
| 8 | Crizotinib | FAERS: 1 | US FAERS | |
| 9 | Diphenhydramine | FAERS: 1 | US FAERS | |
| 10 | Levetiracetam | FAERS: 1 | US FAERS | |
| 11 | Levofloxacin | FAERS: 1 | US FAERS | |
| 12 | Norgestrel | FAERS: 1 | US FAERS | |
| 13 | Pramipexole | FAERS: 1 | US FAERS | |
| 14 | Ranolazine | FAERS: 1 | US FAERS | |
| 15 | Vigabatrin | FAERS: 1 | US FAERS | |
| 16 | alogliptin | FAERS: 1 | US FAERS | |
| 17 | teriflunomide | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120242
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.